 |
| |
WELCOME |
|
| |
|
"The UK tissue engineering research bias
is towards biomedical and bioengineering applications which
tackle long term disabling and chronically painful conditions.
Major improvements would be possible across all areas of tumour/abdominal,
neural, ocular, dermal and vascular surgery if suitable tissue
engineered implants were available" (Foresight
2020, Healthcare report - Peckham 2000) |
|
| |
|
| |
|
| |
|
| |
|
Tissue engineering only operates in reality
where its component disciplines overlap. Interdisciplinary gaps
to be bridged between cell biologists, surgeons, engineers and
materials scientists cannot be overestimated. We must link stem-cell
acquisition/selection and expansion with new knowledge on control
of differentation and cell cuing. Process engineering involved
in functional 3D tissue bioreactors, their dynamic controls,
monitoring and regulation represent major challenges. Questions
of tissue integration and rejection together with suitable bio-interactive
and dynamic support materials continue to limit progress. |
|
| |
|
| |
|
| |
|
| |
|
It is essential to set up a network
now pulling together all the elements of UK tissue engineering.
The initial linkage will be between a few focal centres with
progressive growth. |
|
| |
|
| |
|
| |
|
